About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
The University of Kansas Cancer Center
https://www.kucancercenter.org/
2023 Multidisciplinary Oncology Review
2022
Advances in Hematologic Malignancies and Cellular Therapeutics Symposium
2022 Post San Antonio Review
Videos
2021
2021 Virtual KU Hematology and Medical Oncology Review
2021 Post San Antonio Review
2021 KUMC Virtual Multidisciplinary Oncology Review
2020
ASH Review VIRTUAL 2020: Current Updates in Hematologic Diseases
2020 ASCO Highlights
2019
2019 Post San Antonio Breast Cancer Review
ASH 2019 Review: Current Updates in Hematologic Diseases
2019 Lung Cancer and Head & Neck Cancer Symposium
Hematology & Medical Oncology Review 2019
Lung
Hematologic Malignancies
Gastrointestinal
Head and Neck
Genitourinary
Skin
Palliative
General
Event
2018
ASH: Current Updates in Hematologic Diseases
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
R
KU ASCO 2019 Updates on Hepatobiliary Cancer: Pembrolizumab vs. Best Supportive Care, Nivolumab Alone vs. Combo, and Genetic Targets
By
KU Hematology & Medical Oncology Review 2019
FEATURING
Raed Al-Rajabi
By
KU Hematology & Medical Oncology Review 2019
FEATURING
Raed Al-Rajabi
412 views
August 21, 2019
0 Comments
Login to view comments.
Click here to Login
Featured Video
24:35
Indy Hematology Review
Current Approaches in the Treatment of Myeloproliferative Neoplasms
Feat.
A. Tefferi
Featured Video
08:18
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Treatment Strategies for Hematocrit Control…
Feat.
A. Zhou
Gastrointestinal
14:39
KU Hematology & Medical Oncology Review 2019
KU ASCO 2019 Updates on Pancreatic Cancer: Maintenance Olaparib and …
Feat.
R. Al-Rajabi
16:20
KU Hematology & Medical Oncology Review 2019
KU ASCO 2019 Updates on Hepatobiliary Cancer: Pembrolizumab vs. Best…
Feat.
R. Al-Rajabi
19:12
KU Hematology & Medical Oncology Review 2019
Management of Toxicities in Neoadjuvant (Perioperative) Chemotherapy…
Feat.
W. Sun
18:29
KU Hematology & Medical Oncology Review 2019
Anti-PD-1 Therapy and Dose Modification in Advanced Gastroesophageal…
Feat.
W. Sun